Both in Biotechnology
Eikon Therapeutics vs Agenus
Over the past year EIKN returned −59.9% and AGEN returned +151.3%; their daily moves had a correlation of 0.26.
EIKN −59.9% AGEN +151.3%Growth of $1, one year, split-adjusted
| Metric | EIKN | AGEN |
|---|---|---|
| Price | $6.01 | $6.96 |
| Market cap | $325.5M | $314.3M |
| Today | +8.29% | +4.35% |
| 1 month | −20.0% | −7.1% |
| 6 months | −39.7% | +78.9% |
| Year to date | — | +121.7% |
| 1 year | — | +75.3% |
| Revenue growth (YoY) | — | +34.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | 3.4× |
| Price / sales | — | 2.4× |
| Net cash | $531.2M | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 100.8% | 88.8% |
| Short % of float | 20.4% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).